Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BALSALAZIDE vs BAMLANIVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BALSALAZIDE vs BAMLANIVIMAB: Safety Overview

Metric BALSALAZIDE BAMLANIVIMAB
Total FAERS Reports 239 5,280
Deaths Reported 9 307
Death Rate 3.8% 5.8%
Hospitalizations 64 2,175
Average Patient Age 50.6 yrs 63.6 yrs
% Female Patients 59.8% 50.5%
FDA Approval Date Apr 3, 2025 N/A
Manufacturer AvPAK N/A
Route ORAL N/A
Marketing Status Prescription N/A